• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染后患乳糜泻的风险。

The risk for celiac disease after Covid-19 infection.

机构信息

Department of Gastroenterology and Nutrition, Department of Clinical Sciences, Skåne University Hospital, Lund University, Malmö, Sweden.

Division of Medical Microbiology, Department of Laboratory Medicine, Skåne University Hospital, Lund University, Lund, Sweden.

出版信息

BMC Gastroenterol. 2023 May 22;23(1):174. doi: 10.1186/s12876-023-02795-3.

DOI:10.1186/s12876-023-02795-3
PMID:37217874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10202072/
Abstract

BACKGROUND

Celiac disease (CD) is an autoimmune disease leading to gastrointestinal symptoms and mineral deficiencies. The pathogenetic mechanisms, besides the clear HLA association, are elusive. Among environmental factors infections have been proposed. Covid-19 infection results in a systemic inflammatory response that often also involves the gastrointestinal tract. The aim of the present study was to investigate whether Covid-19 infection could increase the risk for CD.

PATIENTS AND METHODS

All patients, both children and adults, in the county Skåne (1.4 million citizens) in southern Sweden with newly diagnosed biopsy- or serology-verified CD or a positive tissue transglutaminase antibody test (tTG-ab) during 2016-2021 were identified from registries at the Departments of Pathology and Immunology, respectively. Patients with a positive Covid-19 PCR or antigen test in 2020 and 2021 were identified from the Public Health Agency of Sweden.

RESULTS

During the Covid-19 pandemic (March 2020 - December 2021), there were 201 050 cases of Covid-19 and 568 patients with biopsy- or serology-verified CD or a first-time positive tTG-ab tests, of which 35 patients had been infected with Covid-19 before CD. The incidence of verified CD and tTG-ab positivity was lower in comparison to before the pandemic (May 2018 - February 2020; 22.5 vs. 25.5 cases per 100 000 person-years, respectively, incidence rate difference (IRD) -3.0, 95% CI -5.7 - -0.3, p = 0.028). The incidence of verified CD and tTG-ab positivity in patients with and without prior Covid-19 infection was 21.1 and 22.4 cases per 100 000 person-years, respectively (IRD - 1.3, 95% CI -8.5-5.9, p = 0.75).

CONCLUSIONS

Our results indicate that Covid-19 is not a risk factor for CD development. While gastrointestinal infections seem to be an important part of the CD pathogenesis, respiratory infections probably are of less relevance.

摘要

背景

乳糜泻(CD)是一种自身免疫性疾病,可导致胃肠道症状和矿物质缺乏。除了明确的 HLA 相关性之外,其发病机制仍不清楚。环境因素中,感染已被提出为一个致病因素。新冠病毒感染会导致全身炎症反应,而这种反应通常也会涉及胃肠道。本研究旨在探讨新冠病毒感染是否会增加 CD 的发病风险。

患者和方法

从病理和免疫学部的登记处分别鉴定出 2016 年至 2021 年期间在瑞典斯科讷县(140 万居民)新诊断出活检或血清学证实的 CD 或组织转谷氨酰胺酶抗体检测(tTG-ab)阳性的所有患者,包括儿童和成人。从瑞典公共卫生局鉴定出 2020 年和 2021 年新冠病毒 PCR 或抗原检测阳性的患者。

结果

在新冠疫情期间(2020 年 3 月至 2021 年 12 月),有 201050 例新冠病例和 568 例活检或血清学证实的 CD 或首次 tTG-ab 阳性患者,其中 35 例患者在 CD 之前曾感染过新冠病毒。与疫情前(2018 年 5 月至 2020 年 2 月)相比,确诊 CD 和 tTG-ab 阳性的发病率较低(分别为每 100000 人年 22.5 例和 25.5 例,发病率差异(IRD)-3.0,95%CI-5.7 至-0.3,p=0.028)。有和没有新冠病毒感染史的患者中确诊 CD 和 tTG-ab 阳性的发病率分别为每 100000 人年 21.1 例和 22.4 例(IRD-1.3,95%CI-8.5 至 5.9,p=0.75)。

结论

我们的结果表明新冠病毒不是 CD 发病的危险因素。虽然胃肠道感染似乎是 CD 发病机制的重要组成部分,但呼吸道感染的相关性可能较小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cc/10204215/2f2ea91f0332/12876_2023_2795_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cc/10204215/4805ed24c1d1/12876_2023_2795_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cc/10204215/2f2ea91f0332/12876_2023_2795_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cc/10204215/4805ed24c1d1/12876_2023_2795_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cc/10204215/2f2ea91f0332/12876_2023_2795_Fig2_HTML.jpg

相似文献

1
The risk for celiac disease after Covid-19 infection.新冠病毒感染后患乳糜泻的风险。
BMC Gastroenterol. 2023 May 22;23(1):174. doi: 10.1186/s12876-023-02795-3.
2
Accuracy of HLA-DQ genotyping in combination with IgA anti-tissue transglutaminase serology and a "scoring system" for the diagnosis of celiac disease in Turkish children.土耳其儿童中 HLA-DQ 基因分型联合 IgA 抗组织转谷氨酰胺酶血清学及“评分系统”用于诊断乳糜泻的准确性
Turk J Pediatr. 2014 Jul-Aug;56(4):347-53.
3
Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population.北美儿科人群中欧洲儿科胃肠病、肝病和营养学会乳糜泻指南的评估。
Am J Gastroenterol. 2015 May;110(5):760-7. doi: 10.1038/ajg.2015.87. Epub 2015 Mar 31.
4
Antitissue transglutaminase and antithyroid autoantibodies in children with Down syndrome and celiac disease.唐氏综合征合并乳糜泻患儿的抗组织转谷氨酰胺酶和抗甲状腺自身抗体
J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):170-4; discussion 125-7. doi: 10.1097/00005176-200502000-00016.
5
Transglutaminase antibodies and celiac disease in children with type 1 diabetes and in their family members.转谷氨酰胺酶抗体与 1 型糖尿病患儿及其家庭成员的乳糜泻
Pediatr Diabetes. 2018 Mar;19(2):305-313. doi: 10.1111/pedi.12563. Epub 2017 Jul 26.
6
Screening for celiac disease in Down's syndrome patients revealed cases of subtotal villous atrophy without typical for celiac disease HLA-DQ and tissue transglutaminase antibodies.对唐氏综合征患者进行乳糜泻筛查时发现了一些病例,这些病例存在绒毛萎缩不全,但没有乳糜泻典型的HLA - DQ和组织转谷氨酰胺酶抗体。
World J Gastroenterol. 2006 Mar 7;12(9):1430-4. doi: 10.3748/wjg.v12.i9.1430.
7
Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients.组织转谷氨酰胺酶酶联免疫吸附测定作为儿科患者乳糜泻的筛查试验。
Pediatrics. 2001 Jan;107(1):E8. doi: 10.1542/peds.107.1.e8.
8
Prevalence and Clinical Features of Celiac Disease in Healthy School-Aged Children.学龄期健康儿童中乳糜泻的患病率及临床特征。
Dig Dis Sci. 2019 Jan;64(1):173-181. doi: 10.1007/s10620-018-5320-0. Epub 2018 Oct 12.
9
Celiac disease can be predicted by high levels of tissue transglutaminase antibodies in children and adolescents with type 1 diabetes.在 1 型糖尿病患儿和青少年中,组织转谷氨酰胺酶抗体水平升高可预测乳糜泻。
Pediatr Diabetes. 2021 May;22(3):417-424. doi: 10.1111/pedi.13165. Epub 2020 Dec 12.
10
Tissue transglutaminase antibodies are a useful serological marker for the diagnosis of celiac disease in patients with Down syndrome.组织转谷氨酰胺酶抗体是诊断唐氏综合征患者乳糜泻的一种有用的血清学标志物。
J Pediatr Gastroenterol Nutr. 2007 May;44(5):583-6. doi: 10.1097/MPG.0b013e3180320679.

引用本文的文献

1
SARS-CoV-2 Vaccination Coverage in Italian Children with Celiac Disease.意大利乳糜泻患儿的新冠病毒疫苗接种覆盖率
J Clin Med. 2024 Sep 30;13(19):5851. doi: 10.3390/jcm13195851.

本文引用的文献

1
The Influence of SARS-CoV-2 Pandemic on the Diagnosis of Celiac Disease and Clinical Practice in Pediatric Gastroenterology.SARS-CoV-2 大流行对儿科胃肠病学中乳糜泻诊断和临床实践的影响。
Nutrients. 2023 Jan 21;15(3):559. doi: 10.3390/nu15030559.
2
Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis.新冠病毒感染后发生糖尿病的风险:系统评价和荟萃分析。
Metabolism. 2022 Dec;137:155330. doi: 10.1016/j.metabol.2022.155330. Epub 2022 Oct 8.
3
Homologous and Heterologous Anti-COVID-19 Vaccination Does Not Induce New-Onset Formation of Autoantibodies Typically Accompanying Lupus Erythematodes, Rheumatoid Arthritis, Celiac Disease and Antiphospholipid Syndrome.
同源和异源抗COVID-19疫苗接种不会引发通常伴随红斑狼疮、类风湿性关节炎、乳糜泻和抗磷脂综合征出现的自身抗体新发形成。
Vaccines (Basel). 2022 Feb 18;10(2):333. doi: 10.3390/vaccines10020333.
4
COVID-19 Testing in Sweden During 2020-Split Responsibilities and Multi-Level Challenges.2020 年瑞典的 COVID-19 检测:职责划分与多层次挑战。
Front Public Health. 2021 Nov 19;9:754861. doi: 10.3389/fpubh.2021.754861. eCollection 2021.
5
Two waves of coeliac disease incidence in Sweden: a nationwide population-based cohort study from 1990 to 2015.瑞典的两波乳糜泻发病潮:一项基于人群的全国性队列研究,时间跨度为 1990 年至 2015 年。
Gut. 2022 Jun;71(6):1088-1094. doi: 10.1136/gutjnl-2021-324209. Epub 2021 Jul 28.
6
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.长期康复的 SARS-CoV-2 感染者中独特自身抗体的流行率。
J Autoimmun. 2021 Aug;122:102682. doi: 10.1016/j.jaut.2021.102682. Epub 2021 Jun 21.
7
COVID-19 and celiac disease: A pathogenetic hypothesis for a celiac outbreak.COVID-19 与乳糜泻:乳糜泻爆发的一种发病假说。
Int J Clin Pract. 2021 Sep;75(9):e14452. doi: 10.1111/ijcp.14452. Epub 2021 Jun 17.
8
The SARS-CoV-2 as an instrumental trigger of autoimmunity.SARS-CoV-2 作为自身免疫的工具性触发因素。
Autoimmun Rev. 2021 Apr;20(4):102792. doi: 10.1016/j.autrev.2021.102792. Epub 2021 Feb 19.
9
Enterovirus Infections Are Associated With the Development of Celiac Disease in a Birth Cohort Study.肠道病毒感染与队列研究中乳糜泻发病相关。
Front Immunol. 2021 Feb 2;11:604529. doi: 10.3389/fimmu.2020.604529. eCollection 2020.
10
COVID-19 and autoimmune diseases.新型冠状病毒肺炎与自身免疫性疾病。
Curr Opin Rheumatol. 2021 Mar 1;33(2):155-162. doi: 10.1097/BOR.0000000000000776.